Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.

Hassamal S, Waller S, Reese K, Testa C.

Turk Psikiyatri Derg. 2016 Fall;27(3):213-217. Turkish, English.

2.

Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

Wirdefeldt K, Odin P, Nyholm D.

CNS Drugs. 2016 May;30(5):381-404. doi: 10.1007/s40263-016-0336-5. Review.

PMID:
27138916
3.

New and emerging treatments for Parkinson disease.

Fung VS.

Med J Aust. 2015 Apr 6;202(6):283-4. No abstract available.

PMID:
25832138
4.

Dystonia.

Snaith A, Wade D.

BMJ Clin Evid. 2014 Feb 28;2014. pii: 1211.

5.

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology..

Neurology. 2006 Apr 11;66(7):983-95. Review.

PMID:
16606909
6.

Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations.

Hempel AG, Wagner ML, Maaty MA, Sage JI.

Ann Pharmacother. 1998 Sep;32(9):878-83.

PMID:
9762373

Supplemental Content

Loading ...
Support Center